Eventide Asset Management, LLC Amicus Therapeutics, Inc. Transaction History

Eventide Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 29, 2020	SELL	$7.48 - $10.75 $14.6 Million - $21 Million	-1,950,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $3.67 Million - $4.82 Million	335,000 Added 20.74%	1,950,000 $24.3 Million
Q1 2019 May 15, 2019	BUY	$10.04 - $13.92 $2.8 Million - $3.88 Million	279,000 Added 20.88%	1,615,000 $22 Million
Q4 2018 Feb 14, 2019	BUY	$8.38 - $13.44 $5.33 Million - $8.55 Million	636,000 Added 90.86%	1,336,000 $12.8 Million
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $8.12 Million - $11.6 Million	700,000 New	700,000 $8.46 Million

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.